These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4604574)

  • 1. Immunotherapy of coccidioidomycosis.
    Catanzaro A; Spitler L; Moser KM
    J Clin Invest; 1974 Sep; 54(3):690-701. PubMed ID: 4604574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen.
    Cox RA; Brummer E; Lecara G
    Infect Immun; 1977 Mar; 15(3):751-5. PubMed ID: 870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response in coccidioidomycosis.
    Catanzaro A; Spitler LE; Moser KM
    Cell Immunol; 1975 Feb; 15(2):360-71. PubMed ID: 1089482
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immumologic responses of persons with primary, asymptomatic infections.
    Cox RA; Vivas JR; Gross A; Lecara G; Miller E; Brummer E
    Am Rev Respir Dis; 1976 Nov; 114(5):937-43. PubMed ID: 791035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of mycelia- and spherule-derived antigens in cellular immune assays of Coccidioides immitis-infected guinea pigs.
    Cox RA; Mead CG; Pavey EF
    Infect Immun; 1981 Feb; 31(2):687-92. PubMed ID: 7012017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen.
    Harvey RP; Stevens DA
    Am Rev Respir Dis; 1981 Jun; 123(6):665-9. PubMed ID: 7271066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in recurrent coccidioidomycosis.
    Stevens DA; Pappagianis D; Marinkovich VA; Waddell TF
    Cell Immunol; 1974 Apr; 12(1):37-48. PubMed ID: 4458962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy of coccidiomycosis].
    Graybill JR
    Bull Int Union Tuberc; 1976; 51(1 Pt 2):529-33. PubMed ID: 802716
    [No Abstract]   [Full Text] [Related]  

  • 10. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults.
    Ampel NM; Bejarano GC; Salas SD; Galgiani JN
    J Infect Dis; 1992 Apr; 165(4):710-5. PubMed ID: 1552200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by cell wall antigens of Coccidioides immitis.
    Cox RA
    Rev Infect Dis; 1988; 10 Suppl 2():S415-8. PubMed ID: 3263691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis.
    Opelz G; Scheer MI
    J Infect Dis; 1975 Sep; 132(3):250-5. PubMed ID: 1159328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.
    Ampel NM; Nelson DK; Chavez S; Naus KA; Herman AB; Li L; Simmons KA; Pappagianis D
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):700-4. PubMed ID: 15939743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis.
    Richards JO; Ampel NM; Lake DF
    J Immunol; 2002 Aug; 169(4):2020-5. PubMed ID: 12165528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis.
    Cox RA; Pope RM
    Infect Immun; 1987 May; 55(5):1058-62. PubMed ID: 3552984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coccidioidomycosis: early immunologic findings.
    Miller CH; MacKenzie MR; Paglieroni T; Goldstein E
    West J Med; 1983 Jan; 138(1):55-9. PubMed ID: 6601331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
    Newberry WM; Sanford JP
    J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present status of vaccination against coccidioidomycosis in man.
    Pappagianis D; Levine HB
    Am J Epidemiol; 1975 Jul; 102(1):30-41. PubMed ID: 1155435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.